Small protein DDX11-AS1-ORF encoded by lncRNA DDX11-AS1 promotes colorectal cancer progression through

Yuanfang Cheng1, Jiajie Dong1, Kai Shang2

  • 1Department of Biochemistry and Molecular Biology, Sanquan College of Xinxiang Medical University, School of Basic Medicine Xinxiang 453513, Henan, P. R. China.

Insights

The small protein DDX11-AS1-ORF, encoded by DDX11-AS1, promotes colorectal cancer (CRC) progression. It enhances tumor proliferation, migration, and angiogenesis by activating the VEGFA/p38-MAPK pathway, offering a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) progression involves complex molecular mechanisms.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
  • The functional role of small proteins encoded by lncRNAs in CRC remains underexplored.

Purpose of the Study:

  • To investigate the expression, function, and mechanism of the small protein DDX11-AS1-ORF in colorectal cancer (CRC).
  • To elucidate the role of DDX11-AS1 and its encoded protein in CRC progression.
  • To identify potential therapeutic targets for CRC.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for gene expression analysis.
  • Cell counting kit-8 (CCK8), colony formation, Transwell migration, and in vitro tube formation assays for functional evaluation.
  • Western blot and immunofluorescence for protein validation and pathway analysis.
  • Inhibition of the p38-MAPK pathway using SB203580.

Main Results:

  • DDX11-AS1 was significantly upregulated in CRC tissues and cells.
  • DDX11-AS1 translated into a functional small protein, DDX11-AS1-ORF, promoting CRC cell proliferation, migration, and angiogenesis.
  • DDX11-AS1-ORF activated the p38-MAPK signaling pathway via VEGFA, driving tumor progression.
  • Inhibition of p38-MAPK pathway suppressed DDX11-AS1-ORF-mediated tumor promotion.

Conclusions:

  • The small protein DDX11-AS1-ORF, derived from DDX11-AS1, is a key driver of colorectal cancer.
  • DDX11-AS1-ORF promotes CRC by enhancing proliferation, migration, and angiogenesis through the VEGFA/p38-MAPK pathway.
  • DDX11-AS1-ORF represents a novel and promising molecular target for CRC therapy.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.5K